HURN
Huron Consulting Group Inc. NASDAQ$132.22
Mkt Cap $2.2B
52w Low $116.12
22.8% of range
52w High $186.78
50d MA $130.70
200d MA $148.52
P/E (TTM)
21.8x
EV/EBITDA
17.6x
P/B
4.3x
Debt/Equity
1.0x
ROE
19.9%
P/FCF
16.5x
RSI (14)
—
ATR (14)
—
Beta
0.19
50d MA
$130.70
200d MA
$148.52
Avg Volume
323.8K
About
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transforma…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.58 | 1.73 | +9.5% | — | — | — | — | — | — | — | — |
| Feb 24, 2026 | AMC | 1.94 | 2.17 | +11.9% | 126.36 | +1.9% | +5.5% | +13.4% | +11.9% | +14.3% | +17.5% | — |
| Oct 28, 2025 | AMC | 1.88 | 2.10 | +11.7% | 152.48 | +2.3% | +11.2% | +8.5% | +7.8% | +8.7% | +8.2% | — |
| Jul 31, 2025 | AMC | 1.79 | 1.89 | +5.6% | 132.08 | -2.2% | -7.6% | -4.2% | -3.2% | -2.4% | -0.3% | — |
| Apr 29, 2025 | AMC | 1.16 | 1.68 | +44.8% | 135.94 | -4.1% | -0.8% | +3.7% | +8.4% | +9.1% | +9.8% | — |
| Feb 25, 2025 | AMC | 1.52 | 1.90 | +25.0% | 125.33 | +7.1% | +18.2% | +19.3% | +21.6% | +18.4% | +17.8% | — |
| Oct 29, 2024 | AMC | 1.57 | 1.68 | +7.0% | 104.99 | +4.5% | +10.6% | +10.2% | +9.6% | +12.6% | +14.6% | — |
| Jul 30, 2024 | AMC | 1.48 | 1.68 | +13.5% | 112.93 | -2.6% | -2.6% | -0.5% | -3.9% | -7.3% | -9.1% | — |
| Apr 30, 2024 | AMC | 0.89 | 1.23 | +38.2% | 93.24 | -3.4% | -6.6% | -8.2% | -7.4% | -6.8% | -6.0% | — |
| Feb 27, 2024 | AMC | 1.12 | 1.29 | +15.2% | 107.36 | -3.9% | -12.5% | -8.6% | -7.4% | -8.4% | -9.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 | Wedbush | Maintains | Outperform → Outperform | — | $181.34 | $181.12 | -0.1% | +1.0% | +1.2% | +1.3% | +2.3% | +1.2% |
| Jan 5 | Barrington Research | Maintains | Outperform → Outperform | — | $171.05 | $170.89 | -0.1% | +5.8% | +4.1% | +4.8% | +4.4% | +6.0% |
| Dec 24 | Benchmark | Maintains | Buy → Buy | — | $178.20 | $179.37 | +0.7% | +1.0% | +1.4% | +0.6% | -1.6% | -3.0% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $161.77 | $162.36 | +0.4% | +2.3% | -0.8% | -0.5% | +0.4% | +0.7% |
| Oct 29 | Benchmark | Maintains | Buy → Buy | — | $152.48 | $156.00 | +2.3% | +11.2% | +8.5% | +7.8% | +8.7% | +8.2% |
| Aug 7 | Barrington Research | Maintains | Outperform → Outperform | — | $128.91 | $129.10 | +0.1% | +2.2% | +3.2% | +1.8% | +2.6% | +6.3% |
| May 5 | Barrington Research | Maintains | Outperform → Outperform | — | $147.36 | $146.15 | -0.8% | +0.6% | +1.3% | +2.3% | +3.3% | +2.1% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $142.51 | $142.53 | +0.0% | +0.1% | -0.1% | +0.7% | +2.7% | +3.7% |
| Mar 26 | Benchmark | Maintains | Buy → Buy | — | $145.00 | $145.79 | +0.5% | -1.7% | -1.6% | -1.9% | -1.1% | +1.0% |
| Mar 26 | Wedbush | Maintains | Outperform → Outperform | — | $145.00 | $145.79 | +0.5% | -1.7% | -1.6% | -1.9% | -1.1% | +1.0% |
Recent Filings
Data updated apr 25, 2026 2:24pm
· Source: massive.com